Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07821671 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study

Name: Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study — clinical trial record (NCT07821671)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhaseNot applicable

SponsorEmory University

Started2027-03-01

View on ClinicalTrials.gov ↗

Emory University

371 trials monitored

See 23 trials at risk

This study uses a rapid randomized controlled trial (RCT) design to examine HIV pre-exposure prophylaxis (PrEP) delivered through telehealth. This study will develop a knowledge base of small, effective changes to digital messaging and website design to improve telemedicine PrEP (telePrEP) provision for MISTR users in the United States.

Trial Details

NCT Number	NCT07821671
Lead Sponsor	Emory University Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions	Human Immunodeficiency Virus
Enrollment	223,165 participants
Start Date	2027-03-01
Primary Completion	2031-05-31 (estimated)
Study Completion	2031-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-09-16